HOME
• lamictal and remeron
• cymbalta withdrawal while taking remeron
• remeron migraine
• deaths resulting from remeron

remeron more drug_uses

Families and remeron more drug_uses of patients being treated with antidepressants for major depressive disorder or other indications, both psychiatric and nonpsychiatric, should be alerted about the need to monitor patients for the emergence of agitation, irritability, unusual changes in behavior, and the other symptoms described above, as well as the emergence of suicidality, and to report such remeron more drug_uses immediately to health care providers. John's wort, and most tricyclic antidepressants) (see CONTRAINDICATIONS and PRECAUTIONS: Drug Interactions). Systematic evaluation of Remeron (mirtazapine) Tablets has demonstrated that its efficacy in major depressive disorder is maintained for periods of up to 40 weeks following 8 to 12 weeks of initial treatment at a remeron more drug_uses of 15 to 45 mg/day (see CLINICAL PHARMACOLOGY). INCIDENCE OF ADVERSE CLINICAL EXPERIENCES* (≥1%) IN SHORT-TERM US CONTROLLED STUDIES Body System   Adverse Clinical Experience Remeron (n=453) Placebo (n=361) * Events reported by at least 1% of patients treated with Remeron are included, except the following events which had remeron more drug_uses incidence on placebo greater than or equal to Remeron: headache, infection, pain, chest pain, palpitation, tachycardia, postural hypotension, nausea, dyspepsia, diarrhea, flatulence, insomnia, nervousness, libido decreased, hypertonia, pharyngitis, rhinitis, sweating, amblyopia, tinnitus, taste perversion. Call your remeron more drug_uses for medical advice about side effects.

Go To...

• remeron research
• remeron and org
• remeron and anxiety relief
• remeron multiple sclerosis
• remeron with effexor

remeron more drug_uses

These risk differences (drug-placebo difference in the number of cases of suicidality per 1000 patients treated) are provided in Table 1. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider. Read it again each time you get Remeron refilled. Hepatic Insufficiency Following a single 15-mg oral remeron more drug_uses of Remeron, the oral clearance of mirtazapine was decreased by approximately 30% in hepatically impaired patients compared to subjects with normal hepatic function. Only your remeron more drug_uses can determine if it is safe for you to continue taking Remeron. A patient Medication Guide about "Antidepressant Medicines, Depression and other Serious Mental Illnesses, and Suicidal Thoughts or Actions" is available for RemeronSolTab. Cases of severe skin reactions, including Stevens-Johnson Syndrome, bullous dermatitis, erythema multiforme and toxic epidermal necrolysis have also been reported. Numerous cases of mirtazapine- induced arthralgia have remeron more drug_uses reported. The clinical significance of these changes is unknown. Below is just a partial list. It is thought to increase the activity of certain chemicals in the brain (norepinephrine, serotonin), which help elevate mood. Physical and Psychologic Dependence RemeronSolTab (mirtazapine) Orally Disintegrating Tablets have not been systematically studied in animals or humans for its potential for abuse, tolerance, or physical dependence. Consequently, the prescriber should be aware that plasma mirtazapine levels may be increased in these patient groups, compared to levels observed in younger adults without renal or hepatic impairment (see PRECAUTIONS and CLINICAL PHARMACOLOGY). Special Senses: infrequent: eye pain, abnormality of accommodation, conjunctivitis, deafness, keratoconjunctivitis, lacrimation disorder, glaucoma, hyperacusis, ear pain; rare: blepharitis, partial transitory deafness, otitis media, taste loss, parosmia. RemeronSolTab also contains the following inactive ingredients: aspartame, citric acid, crospovidone, hypromellose, magnesium stearate, mannitol, microcrystalline cellulose, natural and artificial orange flavor, polymethacrylate, povidone, sodium bicarbonate, starch, and sucrose. The frequencies presented, therefore, represent the proportion of the 2796 patients exposed to multiple doses of Remeron who experienced an event of the type cited on at least 1 occasion while receiving Remeron. Mirtazapine has no significant affinity for the 5-HT1A and 5-HT1B receptors. Major pathways of bio-transformation are demethylation and hydroxylation followed by glucuronide conjugation. Increased Appetite/Weight Gain In US controlled studies, appetite increase was reported in 17% of patients treated with Remeron, compared remeron more drug_uses 2% for placebo and 6% for amitriptyline. Do NOT use Remeron if: you are allergic to any ingredient in Remeron you are taking furazolidone you are taking or have taken a monoamine oxidase inhibitor (MAOI) (eg, phenelzine) within the last 14 days Contact your doctor or health care provider right away if any of these apply to you. Similarly, the cited frequencies cannot be compared with figures obtained from other investigations involving different treatments, uses, and investigators. PREGNANCY and BREAST-FEEDING: If you become pregnant, contact remeron more drug_uses doctor. Remeron may also be used for other purposes not listed in this medication guide. Information for Patients Prescribers or other health professionals should inform patients, their families, and their caregivers about the benefits and risks associated with treatment with RemeronSolTab (mirtazapine) Orally Disintegrating Tablets and should counsel them in its appropriate use. No water is needed. Mirtazapine is usually taken once a day at bedtime. Call remeron more drug_uses doctor at once if you have a serious side effect while using Remeron, such as: agitation, hallucinations, fever, fast heart rate, overactive reflexes, nausea, vomiting, diarrhea, loss of coordination, fainting; fever, chills, body aches, flu symptoms; white patches or sores inside your mouth or on your lips; or headache, trouble concentrating, memory problems, weakness, feeling unsteady, or confusion. Consequently, the prescriber should be aware that plasma mirtazapine levels may be increased in these patient groups, compared to levels observed in younger adults without renal or hepatic impairment (see PRECAUTIONS and CLINICAL PHARMACOLOGY). The reduction in REM remeron more drug_uses is greatest early in treatment, but gradually returns towards baseline during long-term therapy; however, ROL remains long. Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.